TY - JOUR T1 - Correction: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - 1634 LP - 1634 DO - 10.1136/annrheumdis-2016-210094corr1 VL - 76 IS - 9 A2 - , Y1 - 2017/09/01 UR - http://ard.bmj.com/content/76/9/1634.abstract N2 - Dougados M, van der Heijde D, Chen Y-C, et al. Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the … ER -